We are live on
!
Find out more
JA
JLB & Associates Portfolio holdings
AUM
$696M
1-Year Est. Return
17.86%
This Fund
S&P 500
This Quarter
Est. Return
+11.56%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$544M
AUM Growth
+$43M
(+8.6%)
Cap. Flow
-$11.4M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
38.49%
Holding
70
New
1
Increased
28
Reduced
34
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$4.74M |
| 2 |
Northrop Grumman
NOC
|
+$1.56M |
| 3 |
SEI Investments
SEIC
|
+$1.04M |
| 4 |
Icon
ICLR
|
+$970K |
| 5 |
Diageo
DEO
|
+$673K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$9.42M |
| 2 |
Apple
AAPL
|
+$4.26M |
| 3 |
Microsoft
MSFT
|
+$1.56M |
| 4 |
Global Payments
GPN
|
+$1.51M |
| 5 |
Copart
CPRT
|
+$846K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.26% |
| 2 | Industrials | 19.09% |
| 3 | Consumer Discretionary | 17.09% |
| 4 | Financials | 14.08% |
| 5 | Healthcare | 13.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
51
DELISTED
Kellanova
K
| $2.02M | 0.37% |
33,306
-736
| -2% | -$46.7K |
|
52
Credit Acceptance
CACC
$5.95B
| $2M | 0.37% |
5,918
+6
| +0.1% | +$2.52K |
|
53
CBRE Group
CBRE
$42.5B
| $1.97M | 0.36% |
41,975
+225
| +0.5% | +$10.3K |
|
54
Mettler-Toledo International
MTD
$28.6B
| $1.94M | 0.36% |
2,006
-200
| -9% | -$186K |
|
55
Progressive
PGR
$123B
| $1.31M | 0.24% |
13,879
+1,790
| +15% | +$161K |
|
56
Genpact
G
$5.96B
| $998K | 0.18% |
25,631
+8,929
| +53% | +$352K |
|
57
Cadence Design Systems
CDNS
$93.6B
| $995K | 0.18% |
9,332
-603
| -6% | -$63.4K |
|
58
Visa
V
$684B
| $872K | 0.16% |
4,364
+329
| +8% | +$65.7K |
|
59
F5
FFIV
$22.9B
| $851K | 0.16% |
6,933
+1,876
| +37% | +$252K |
|
60
Casey's General Stores
CASY
$32.2B
| $778K | 0.14% |
4,384
| – | – |
|
61
Globe Life
GL
$14.2B
| $686K | 0.13% |
8,586
| – | – |
|
62
C.H. Robinson
CHRW
$17.4B
| $674K | 0.12% |
6,596
| – | – |
|
63
T. Rowe Price
TROW
$23.9B
| $604K | 0.11% |
4,717
-1,979
| -30% | -$262K |
|
|
DAL
64
DELISTED
DELTA AIR LINES INC DEL
DAL
| $497K | 0.09% |
16,283
-900
| -5% | -$27.5K |
|
65
Churchill Downs
CHDN
$5.88B
| $437K | 0.08% |
5,336
+494
| +10% | +$38.3K |
|
66
Snap-on
SNA
$21.2B
| $397K | 0.07% |
2,700
| – | – |
|
67
KLA
KLAC
$239B
| $239K | 0.04% |
+12,350
| New | +$244K |
|
|
FISV
68
Fiserv Inc
FISV
$28.8B
| $218K | 0.04% |
2,125
| – | – |
|
|
VAR
69
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-76,864
| Closed | -$9.42M |
|
Similar funds
AAM
CA
GUB
BBPWM
SCM
KLI
WIC
TCM
JLB & Associates's Q3 2020 Portfolio in Review
As of Q3 2020, JLB & Associates held 70 positions worth $544M, up 8.6% from $501M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 2.9%. JLB & Associates opened 1 new position and exited 1, leaving the 70-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.
- JLB & Associates's largest Q3 2020 buy was KLA: 12,350 shares worth $239K.
- JLB & Associates added most to UnitedHealth in Q3 2020, an estimated $4.74M increase.
- JLB & Associates's biggest Q3 2020 reduction was Apple, cutting an estimated $4.26M.
- JLB & Associates fully exited Varian Medical Systems, Inc. in Q3 2020, selling an estimated $9.42M.
- JLB & Associates's ten largest holdings make up 38% of its $544M portfolio in Q3 2020.
- JLB & Associates opened 1 new position and closed 1 in Q3 2020.
- JLB & Associates's portfolio value rose 8.6% quarter-over-quarter to $544M.
Based on JLB & Associates's 13F filing for Q3 2020, filed 16 Oct 2020.